NCT06296550 Enhancing Digitally Delivered Diabetes Education With Real-Time CGM
| NCT ID | NCT06296550 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Scripps Whittier Diabetes Institute |
| Condition | Diabetes Type 2 |
| Study Type | INTERVENTIONAL |
| Enrollment | 140 participants |
| Start Date | 2025-04-03 |
| Primary Completion | 2027-04-30 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 140 participants in total. It began in 2025-04-03 with a primary completion date of 2027-04-30.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The current research study will add continuous glucose monitoring devices to the evidence-based text messaging diabetes education program for patients with type 2 diabetes for 6 months. Results on the effectiveness of this intervention will be compared for non-insulin using patients.
Eligibility Criteria
Inclusion Criteria: * Diagnosed with type 2 diabetes * Are not currently using a CGM * Are not using insulin therapies * Speak English, Spanish or Arabic * Have A1c between 7.5% and 12.0% in last 90 days * Have a cellphone that can receive/send text messages and counts steps Exclusion Criteria: * Are using insulin therapies * Are pregnant * Are currently using a CGM * Are currently participating in another diabetes-related study
Contact & Investigator
Athena Philis-Tsimikas, MD
PRINCIPAL INVESTIGATOR
Scripps Health
Frequently Asked Questions
Who can join the NCT06296550 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Diabetes Type 2. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06296550 currently recruiting?
Yes, NCT06296550 is actively recruiting participants. Contact the research team at brown.kallie@scrippshealth.org for enrollment information.
Where is the NCT06296550 trial being conducted?
This trial is being conducted at San Diego, United States.
Who is sponsoring the NCT06296550 clinical trial?
NCT06296550 is sponsored by Scripps Whittier Diabetes Institute. The principal investigator is Athena Philis-Tsimikas, MD at Scripps Health. The trial plans to enroll 140 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.